Key terms

About CHRS

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CHRS news

Yesterday 7:43am ET Coherus Biosciences Embarks on Strategic Financial Restructuring by TipRanks May 08 9:09am ET Coherus Biosciences announces clinical collaboration with CRI by TipRanks Apr 15 4:30am ET Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Acadia Healthcare (ACHC) and Coherus Biosciences (CHRS) by TipRanks Apr 08 8:50am ET Coherus data show CHS-1000 acts to reverse myeloid suppression by TipRanks Mar 20 6:16am ET Buy Rating on Coherus Biosciences: Balancing Divestiture with Promising Pipeline and Financial Growth by TipRanks Mar 20 6:06am ET Coherus Biosciences price target lowered to $11 from $13 at H.C. Wainwright by TipRanks Mar 14 8:30pm ET Analysts Offer Insights on Healthcare Companies: Coherus Biosciences (CHRS) and Solid Biosciences (SLDB) by TipRanks Mar 14 1:40pm ET Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), Coherus Biosciences (CHRS) and Autolus Therapeutics (AUTL) by TipRanks Mar 14 7:30am ET Analysts Conflicted on These Healthcare Names: Amedisys (AMED), Cytokinetics (CYTK) and Coherus Biosciences (CHRS) by TipRanks Mar 14 6:15am ET Buy Rating Affirmed for Coherus Biosciences on Strong Sales and Strategic Restructuring by TipRanks Mar 13 4:11pm ET Coherus Biosciences reports Q4 EPS (62c), consensus (12c) by TipRanks Mar 13 2:49pm ET Coherus BioSciences options imply 21.5% move in share price post-earnings by TipRanks Mar 13 8:05am ET Options Volatility and Implied Earnings Moves Today, March 13, 2024 by TipRanks Mar 04 6:35am ET Sandoz acquires CIMERLI business from Coherus BioSciences by TipRanks Feb 22 5:13pm ET Coherus Biosciences Appoints New Director, Boosts Governance by TipRanks Feb 21 8:31am ET Coherus Biosciences announces U.S. launch of UDENYCA ONBODY by TipRanks

No recent press releases are available for CHRS

CHRS Financials

1-year income & revenue

Key terms

CHRS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CHRS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Bruce Garelick was found guilty of insider trading
John Minchillo/AP
Investor found guilty in Trump Media insider trading case
People walk toward an entrance to Disneyland in Anaheim, California on April 24, 2023.
Mario Tama/Getty Images/File
Americans are shopping less but they’re still spending on flights, hotels and Disneyland
Scaffolding and construction netting near an apartment building in New York, US, on Wednesday, Oct. 11, 2023. Monthly fees and expenses for inspections, insurance and climate-friendly upgrades are squeezing residents of the city's many co-op and condo buildings. Photographer: Michael Nagle/Bloomberg
Michael Nagle/Bloomberg/Getty Images
For US renters, the chance of owning a home is going from bad to worse
Close-up detail of the Disney+ app icon on an Apple iPhone 12 Pro smartphone screen, on November 11, 2020. (Photo by Phil Barker/Future Publishing via Getty Images)
Phil Barker/Future Publishing/Getty Images
Disney just had its worst day in a year and a half